Fulgent Genetics, Inc. (FLGT) › Capital ExpendituresFulgent Genetics, Inc. (FLGT) — Capital ExpendituresAnnual figures by period end, from SEC filings.2014-12-31: $731.0K2015-12-31: $2.10M2016-12-31: $3.79M2017-12-31: $2.90M2018-12-31: $2.32M2019-12-31: $1.18M2020-12-31: $35.13M2021-12-31: $23.81M2022-12-31: $18.77M2023-12-31: $22.21M2024-12-31: $40.31M2025-12-31: $22.57M$22.57M2014-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$22.57M-44.0%2026-02-27From 2025-01-012024-12-31$40.31M+81.5%2026-02-27From 2024-01-012023-12-31$22.21M+18.3%2026-02-27From 2023-01-012022-12-31$18.77M-21.2%2025-02-28From 2022-01-012021-12-31$23.81M-32.2%2024-02-28From 2021-01-012020-12-31$35.13M+2872.1%2023-02-28From 2020-01-012019-12-31$1.18M-49.1%2022-02-28From 2019-01-012018-12-31$2.32M-19.8%2020-03-13From 2018-01-012017-12-31$2.90M-23.6%2019-03-22From 2017-01-012016-12-31$3.79M+80.4%2018-03-20From 2016-01-012015-12-31$2.10M+187.3%2017-03-17From 2015-01-012014-12-31$731.0K—2017-03-17From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)